Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective. Issue 1 (2nd January 2016)

Record Type:: Journal Article
Title:: Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective. Issue 1 (2nd January 2016)
Main Title:: Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective
Authors:: Gebauer, Niklas
Biersack, Harald
Czerwinska, Ann-Cathrin
Schemme, Janina
Hardel, Tim Tristan
Bernard, Veronica
Rades, Dirk
Lehnert, Hendrik
Luley, Kim Barbara
Thorns, Christoph
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 57:Issue 1(2016:Jan.)
Journal:: Leukemia & lymphoma
Issue:: Volume 57:Issue 1(2016:Jan.)
Issue Display:: Volume 57, Issue 1 (2016)
Year:: 2016
Volume:: 57
Issue:: 1
Issue Sort Value:: 2016-0057-0001-0000
Page Start:: 226
Page End:: 229
Publication Date:: 2016-01-02
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.3109/10428194.2015.1046863 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 5955.xml